By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…
Read More
Join Andrew Alexis, MD and Hawasatu Dumbuya, PhD, for an informative and interactive webinar on pigmentary disorders: unveiling insights on epidemiology, stigmatization, clinical perspectives, and a breakthrough innovation for hyperpigmentation.…
Read More
Join Dr. Alexis Carrington in Decoding Dermatology: What's the Diagnosis, as she presents a curated image collection from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. This selection…
Read More
JDD Article Highlights Struggling with treatment adherence in your atopic dermatitis (AD) patients? AD is a widespread inflammatory skin condition, but even with various treatment options, poor adherence - especially to…
Read More
Join us for a panel discussion on innovations in the technology and formulation of essential skincare from Neutrogena. Dr Ted Lain and Dr Cheri Frey will be joined by Kenvue…
Read More
Did You Miss It? Published early online in August, the JDD article titled “Dermatologic Procedures for the Treatment of Seborrheic Dermatitis” reviews alternative dermatologic procedures for treating Seborrheic Dermatitis (SD), offering clinicians…
Read More
JDD Article Highlight Curious about the latest in dermatology treatments? Janus Kinase Inhibitors (JAKis) are gaining traction as a powerful tool for various skin conditions—but there’s more to the story.…
Read More
JDD Article Highlight Platelet-rich concentrates (PRCs) have become popular in dermatology for a variety of treatments, but recent reports link their use to blood-borne infections like HIV and hepatitis. While…
Read More
By Allison Sit A National Eczema Association (NEA) study published in JAMA Dermatology identified patient-reported attributes associated with a “flare” of atopic dermatitis. The study sought to develop a clearer…
Read More
JDD Article Highlight Curious about the latest on Poly-L-lactic acid (PLLA)? Read one of JDD’s latest articles titled “A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid…
Read More
by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…
Read More
